Cognition Capital Stock vs Short Term Debt Analysis
CGTX Stock | USD 0.41 0.02 4.65% |
Cognition Therapeutics financial indicator trend analysis is way more than just evaluating Cognition Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cognition Therapeutics is a good investment. Please check the relationship between Cognition Therapeutics Capital Stock and its Short Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.
Capital Stock vs Short Term Debt
Capital Stock vs Short Term Debt Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cognition Therapeutics Capital Stock account and Short Term Debt. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Cognition Therapeutics' Capital Stock and Short Term Debt is 0.56. Overlapping area represents the amount of variation of Capital Stock that can explain the historical movement of Short Term Debt in the same time period over historical financial statements of Cognition Therapeutics, assuming nothing else is changed. The correlation between historical values of Cognition Therapeutics' Capital Stock and Short Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Stock of Cognition Therapeutics are associated (or correlated) with its Short Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Term Debt has no effect on the direction of Capital Stock i.e., Cognition Therapeutics' Capital Stock and Short Term Debt go up and down completely randomly.
Correlation Coefficient | 0.56 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Capital Stock
The total amount of a company's capital funded by shareholders through the issue and subscription of shares.Short Term Debt
Most indicators from Cognition Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cognition Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cognition Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. For more information on how to buy Cognition Stock please use our How to Invest in Cognition Therapeutics guide.Issuance Of Capital Stock is likely to rise to about 11.5 M in 2024, whereas Selling General Administrative is likely to drop slightly above 9.8 M in 2024.
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 893K | 28K | 27K | 25.7K | Depreciation And Amortization | 93K | 235K | 96K | 91.2K |
Cognition Therapeutics fundamental ratios Correlations
Click cells to compare fundamentals
Cognition Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Cognition Stock Analysis
When running Cognition Therapeutics' price analysis, check to measure Cognition Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cognition Therapeutics is operating at the current time. Most of Cognition Therapeutics' value examination focuses on studying past and present price action to predict the probability of Cognition Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cognition Therapeutics' price. Additionally, you may evaluate how the addition of Cognition Therapeutics to your portfolios can decrease your overall portfolio volatility.